The State of Texas Attorney General Takes Legal Action Against Tylenol Manufacturers Concerning Autism Spectrum Claims

Courtroom Action
Ken Paxton, a Trump ally campaigning for the United States Senate, accused the drug companies of concealing safety concerns of acetaminophen

Texas Attorney General Paxton is taking legal action against the makers of acetaminophen, alleging the firms withheld safety concerns that the drug presented to pediatric cognitive development.

The court filing arrives four weeks after Donald Trump publicized an unverified association between using acetaminophen - referred to as paracetamol - during pregnancy and autism spectrum disorder in children.

The attorney general is taking legal action against the pharmaceutical giant, which previously sold the medication, the only pain reliever approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a declaration, he claimed they "misled consumers by gaining financially from suffering and pushing pills without regard for the dangers."

The company says there is lacking scientific proof linking Tylenol to autism.

"These corporations lied for decades, deliberately risking millions to line their pockets," Paxton, a Republican, declared.

Kenvue said in a statement that it was "deeply concerned by the spread of false claims on the reliability of paracetamol and the likely effects that could have on the welfare of American women and children."

On its online platform, the company also mentioned it had "continuously evaluated the pertinent research and there is lacking reliable evidence that shows a established connection between consuming paracetamol and autism."

Groups acting on behalf of doctors and healthcare providers concur.

ACOG has declared acetaminophen - the key substance in Tylenol - is one of the few options for women during pregnancy to manage pain and elevated temperature, which can present serious health risks if ignored.

"In over twenty years of studies on the utilization of acetaminophen in gestation, no reliable research has conclusively proven that the usage of acetaminophen in any trimester of pregnancy results in neurodevelopmental disorders in children," the group stated.

The court filing mentions latest statements from the previous government in asserting the drug is reportedly hazardous.

In recent weeks, Trump caused concern from medical authorities when he told pregnant women to "fight like hell" not to take acetaminophen when sick.

The FDA then issued a notice that doctors should contemplate reducing the use of acetaminophen, while also declaring that "a causal relationship" between the drug and autism in children has not been established.

The Health Department head RFK Jr, who supervises the Food and Drug Administration, had promised in spring to undertake "comprehensive study program" that would identify the cause of autism spectrum disorder in a matter of months.

But authorities warned that finding a unique factor of autism spectrum disorder - considered by experts to be the outcome of a intricate combination of inherited and surrounding conditions - would be difficult.

Autism is a type of permanent neurological difference and disability that impacts how individuals encounter and relate to the surroundings, and is identified using medical professional evaluations.

In his lawsuit, Paxton - aligned with the former president who is seeking US Senate - claims the manufacturer and J&J "deliberately disregarded and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the corporations "remove any promotional materials" that claims acetaminophen is reliable for women during pregnancy.

The Texas lawsuit parallels the concerns of a group of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in two years ago.

A federal judge threw out the lawsuit, declaring research from the parents' expert witnesses was inconclusive.

Christine Cordova
Christine Cordova

A passionate interior designer and productivity enthusiast, sharing insights on workspace optimization.